Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Бусад хувилбаруудыг харуулах (1)

BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality of life. This Cochrane review is an update of a review of the treatment of RA with...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Ruiz Garcia, V, Jobanputra, P, Burls, A, Cabello, J, Vela Casasempere, P, Bort-Marti, S, Kynaston-Pearson, F
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2014

Ижил төстэй зүйлс

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
-н: Ruiz Garcia, V, зэрэг
Хэвлэсэн: (2011)

Certolizumab pegol in therapy for rheumatoid arthritis
-н: Galina Viktorovna Lukina, зэрэг
Хэвлэсэн: (2012-06-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
-н: M Connock, зэрэг
Хэвлэсэн: (2010-10-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
-н: Vera Nikolayevna Amirdjanova, зэрэг
Хэвлэсэн: (2012-10-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
-н: Evgeniy L'vovich Nasonov, зэрэг
Хэвлэсэн: (2011-02-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
-н: Emna Hannech, зэрэг
Хэвлэсэн: (2021-06-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
-н: Dmitry Evgenyevich Karateev, зэрэг
Хэвлэсэн: (2012-04-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
-н: T. V. Korotaeva, зэрэг
Хэвлэсэн: (2015-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
-н: Maria Majdan, зэрэг
Хэвлэсэн: (2014-07-01)

Certolizumab pegol in the treatment of spondyloarthritis
-н: Mariusz Korkosz
Хэвлэсэн: (2014-09-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
-н: Smolen, JS, зэрэг
Хэвлэсэн: (2024)

COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
-н: Purcaru, O, зэрэг
Хэвлэсэн: (2010)

Prefilled certolizumab pegol (Cimzia&reg;) syringes for self-use in the treatment of rheumatoid arthritis
-н: J Rosa, зэрэг
Хэвлэсэн: (2010-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
-н: Sh. F. Erdes
Хэвлэсэн: (2016-02-01)

Eosinophilic Annular Erythema Due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
-н: Andrea Bassi, зэрэг
Хэвлэсэн: (2023-04-01)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
-н: José Alexandre Mendonça, зэрэг
Хэвлэсэн: (2019-02-01)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
-н: Stéphane Paul, зэрэг
Хэвлэсэн: (2020-07-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
-н: Mehmet Baysal, зэрэг
Хэвлэсэн: (2018-09-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
-н: Lindsey J. Wanberg, зэрэг
Хэвлэсэн: (2024-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
-н: Tanaka, Y, зэрэг
Хэвлэсэн: (2023)

Experience with long-term use of certolizumab pegol (Cimzia)
-н: Karine Arnoldovna Lytkina, зэрэг
Хэвлэсэн: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
-н: Karine Arnoldovna Lytkina, зэрэг
Хэвлэсэн: (2013-10-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
-н: Ian R White, зэрэг
Хэвлэсэн: (2022-01-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population
-н: Ian R. White, зэрэг
Хэвлэсэн: (2022-01-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
-н: Vivian P. Bykerk, зэрэг
Хэвлэсэн: (2023-02-01)

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
-н: Glatt, S, зэрэг
Хэвлэсэн: (2019)

Quantitation of certolizumab pegol by validated liquid chromatography methods
-н: Clóvis Dervil Appratto Cardoso Júnior, зэрэг
Хэвлэсэн: (2023-11-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
-н: I.L. Khalif, зэрэг
Хэвлэсэн: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
-н: Ranatunga S, зэрэг
Хэвлэсэн: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
-н: Piotr Wiland, зэрэг
Хэвлэсэн: (2011-08-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
-н: Acosta-Felquer ML, зэрэг
Хэвлэсэн: (2016-03-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
-н: P. I. Novikov, зэрэг
Хэвлэсэн: (2018-07-01)

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
-н: Hazes, J, зэрэг
Хэвлэсэн: (2010)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
-н: A. Spadaro, зэрэг
Хэвлэсэн: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
-н: Wojciech Blonski, зэрэг
Хэвлэсэн: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
-н: O V Knyazev, зэрэг
Хэвлэсэн: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
-н: Yael Sharon, зэрэг
Хэвлэсэн: (2020-06-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
-н: R. Talotta, зэрэг
Хэвлэсэн: (2016-09-01)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
-н: Syuichi Koarada, зэрэг
Хэвлэсэн: (2015-01-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
-н: Jeffrey R. Curtis, зэрэг
Хэвлэсэн: (2017-12-01)